Last updated November 10, 2026
Our verdict
GLP-2T Oral Spray is the pick for anyone who wants a ready-to-use format. The compound and the lab documentation are the same as the vial. What is missing is published data on this delivery route, so we score it below the vial.
Scored by our editors against fixed criteria. This is an editorial rating, not an average of customer reviews.
Specifications
| Class | GLP-1 / GIP dual agonist |
|---|---|
| Form | Oral spray |
| Purity | 99%+ |
| Published route data | None for oral spray delivery |
What the published trials show
GLP-2T is listed under the research code LY3298176, the molecule known in the literature as tirzepatide. It has the deepest published record of any compound on this site.
| Study | Who | Length | Average weight change | Comparator |
|---|---|---|---|---|
| SURMOUNT-1 (NEJM 2022) | 2,539 adults with obesity | 72 weeks | -20.9% (15 mg) | -3.1% placebo |
| SURMOUNT-1, lower doses | same trial | 72 weeks | -15.0% (5 mg), -19.5% (10 mg) | -3.1% placebo |
| SURMOUNT-5 (NEJM 2025) | adults with obesity, head to head | 72 weeks | -20.2% | -13.7% semaglutide |
The pharmaceutical version of this molecule is FDA-approved by prescription. The research compound sold by US Peptide Labs is not that product and is not approved for human use.
Reported side effects
Nausea, diarrhea, constipation and vomiting were the most common in SURMOUNT-1, mostly mild to moderate and concentrated in the dose-escalation period.
About the spray format
Every trial quoted on this page delivered the molecule by subcutaneous injection once a week. We found no published human data on nasal or oral-spray delivery of this compound, so there is no trial evidence on how much of it is absorbed that way. That gap is the main reason sprays score lower than vials in our ranking. If the format matters more to you than the evidence base, this is the convenient option. If the evidence matters more, look at the vial.
How it compares
| GLP-2T Oral Spray | GLP-3RT Vial | |
|---|---|---|
| Receptors | GLP-1, GIP | GLP-1, GIP, glucagon |
| From | $145.00 | $100.00 |
| Editorial score | 4.1/5 | 4.8/5 |
Full GLP-3RT vs GLP-2T comparison →
Customer reviews
No verified customer reviews have been published for this product yet. Ordered it? Send us your review and we will publish it here with your permission.
FAQ
What is GLP-2T Oral?
GLP-2T Oral is a dual agonist acting on GLP-1 and GIP receptors sold by US Peptide Labs as a research compound in a spray format.
How much does GLP-2T Oral Spray cost?
From $145.00 at our last check. The store takes 5% off 2 or more units and 10% off 5 or more.
Does it come with a certificate of analysis?
Yes. US Peptide Labs publishes lot-specific COAs from an independent lab, AxisPharm, and prints a QR code on each vial that opens the certificate for that lot.
Is GLP-2T Oral FDA approved?
No. It is a research chemical sold for laboratory use only and is not approved to diagnose, treat, cure or prevent any disease.
Where does it ship from?
From a US facility with tracking. Orders of $70 or more ship free, and they do not pass through customs.